Host institution of CACA and the CACA guideline system
2022–As the birthplace and host of the China Anti-Cancer Association, it leads the compilation of the CACA integrated cancer care guidelines covering 53 tumor types, promoted nationwide.
Back to home
Grade III-A · National Clinical Research Center
Tianjin Medical University Cancer Institute & Hospital
Breast cancerThyroid cancerGastric cancerLung cancer
Established
1861
Beds
2,400+
Annual Volume
1,600,000+
Tianjin
National benchmark for breast cancer research, among the highest surgical volumes in China.
About the Hospital
Tianjin Medical University Cancer Institute and Hospital is one of the birthplaces of Chinese oncology — originating from an 1861 British military hospital and establishing China’s first oncology department in 1952. It has deep expertise in breast, lung, esophageal and head-and-neck cancers.
The hospital hosts the Chinese Anti-Cancer Association founded by Academician Hao Xishan, leads the national clinical collaboration network, and operates the country’s largest breast cancer prevention and research center.
Hospital Strengths
01A birthplace of Chinese oncology
China’s first oncology department and first oncology monograph both originated here, with a complete academic heritage and training system.
02Nation-leading breast cancer program
Its breast center performs among the highest annual surgical volumes nationally, with mature breast-conservation, reconstruction and sentinel-node techniques.
03A highland for esophageal cancer care
The esophageal MDT is highly experienced in neoadjuvant therapy, minimally invasive esophagectomy and lymphadenectomy.
Key Departments
Breast OncologyLung OncologyEsophageal OncologyGastric OncologyHead & Neck OncologyRadiation OncologyMedical Oncology
Coordinated Treatment Directions
- 01Breast cancer continuum and conservation/reconstruction
- 02Neoadjuvant therapy and minimally invasive esophagectomy
- 03Precision lung surgery and comprehensive care
- 04Radical and reconstructive head-neck surgery
Officially Reported Treatment Milestones
National clinical research center for breast cancer prevention and treatment
2013–Its breast cancer center is a core part of the national clinical research center for malignant tumors, with top national surgical volume and a complete system of breast-conserving and reconstructive techniques.
Accreditations & Platforms
- National Clinical Research Center for Malignant Tumors
- One of the birthplaces of oncology in China